Reuter joined Optima Pharma from an executive position at B. Braun Melsungen AG. As a qualified engineer, he brings to...
Reuter joined Optima Pharma from an executive position at B. Braun Melsungen AG. As a qualified engineer, he brings to...
Based in ICON’s Clinical Pharmacology Unit in San Antonio, US, Elahi will lead ICON’s early phase glucose clamping...
Steve leaves Lundbeck UK after 14 years where he held a variety of senior commercial roles.
Dr Dani Bach (formerly of Index Ventures) joins as Managing Partner, Dr Jacques Mizrahi joins in a consulting role as...
Tasker will lead the Company’s clinical development activities as it advances its rich pipeline of novel GPCR-targeted...
Annika has over twenty years’ experience in the healthcare sector, both as a sell-side analyst and investor. She has a...
John’s career spans twenty years, with extensive experience leading and working with international healthcare...
oseph Bisaha has been named Vice President, Clinical Operations and Project Management, and David Jackson Vice...
Cutler joined ICON in November 2011 as Group President, Clinical Research Services. In his new role as COO, Dr. Cutler...
He replaces Kim Innes, a director with Teva, who will continue for a further year as vice-chair of the...
Henk was at Plant Genetic Systems for a decade, first as a researcher and then as a business development manager....
Guyer M.D. is a long standing member of the US retina community and is currently the Co-Founder and Chief Executive...
Hildemann is a board-certifiedInternist and Cardiologist trained in the U.S. and Germany. In his role asCMO, Hildemann...
Kirsty joins from InVentiv Health’s medical education house, Litmus, where she was a member of the leadership team....
ICON Legal Counsel, Diarmaid Cunningham, has also been elected as Secretary of ACRO for a second term.